M1095-HS-301: A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

sonelokimab (M1095) - Avillion, MoonLake Immunotherap

Jun 1, 2026